vTv Therapeutics Inc. SEC filings VTVT

vTv Therapeutics Inc. has 601 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

vTv Therapeutics Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Bylaw or fiscal year change
Oct 6, 2026 Oct 1, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
Jun 29, 2026 Jun 26, 2026
DEFA14A Additional proxy material Jun 10, 2026 —
424B2 Prospectus May 13, 2026 —
8-K Current report
Other events
May 13, 2026 May 13, 2026
S-8 Employee stock plan registration May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
DEF 14A Proxy statement Apr 28, 2026 Jun 10, 2026
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Material agreement
Feb 2, 2026 Jan 30, 2026
8-K Current report
Bylaw or fiscal year change
Dec 19, 2025 Dec 19, 2025
EFFECT Filing Nov 24, 2025 —
CORRESP Letter to the SEC Nov 20, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
S-3 Shelf registration Oct 3, 2025 —
8-K Current report
Regulation FD disclosure
Sep 10, 2025 Sep 10, 2025
8-K Current report
Material agreement
Sep 2, 2025 Aug 29, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 10, 2025
8-K Current report
Officer or director change
May 19, 2025 May 19, 2025
8-K Current report
Regulation FD disclosure
May 16, 2025 May 16, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEF 14A Proxy statement Apr 25, 2025 Jun 10, 2025
8-K Current report
Officer or director change
Apr 11, 2025 Apr 11, 2025
8-K Current report
Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Other events
Mar 17, 2025 Mar 14, 2025
8-K Current report
Officer or director change
Feb 27, 2025 Feb 24, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Agreement ended
Oct 25, 2024 Oct 22, 2024
S-8 Employee stock plan registration Sep 23, 2024 —
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Other events
Jul 26, 2024 Jul 26, 2024
8-K Current report
Material agreement
Jul 2, 2024 Jun 26, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 11, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
EFFECT Filing Apr 29, 2024 —
424B2 Prospectus Apr 29, 2024 —
424B2 Prospectus Apr 29, 2024 —
CORRESP Letter to the SEC Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 11, 2024
UPLOAD Letter from the SEC Apr 16, 2024 —
S-3 Shelf registration Apr 10, 2024 —
8-K Current report
Other events
Mar 26, 2024 Mar 25, 2024
8-K Current report
Officer or director change
Mar 14, 2024 Mar 13, 2024
10-K Annual report Mar 13, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
D Filing Mar 7, 2024 —
8-K Current report
Regulation FD disclosure
Mar 5, 2024 Mar 5, 2024
8-K Current report
Material agreement, Results of operations, Other events
Feb 28, 2024 Feb 28, 2024
424B5 Prospectus supplement Feb 28, 2024 —
8-K Current report
Material agreement, Officer or director change, Other events
Feb 28, 2024 Feb 23, 2024
8-K Current report
Agreement ended, Officer or director change
Dec 22, 2023 Dec 18, 2023
8-K Current report
Listing notice
Dec 19, 2023 Dec 13, 2023
8-K Current report
Other events
Dec 12, 2023 Dec 11, 2023
8-K Current report
Other events
Nov 20, 2023 Nov 20, 2023
8-K Current report
Other events
Nov 15, 2023 Nov 14, 2023
8-K Current report
Regulation FD disclosure
Nov 15, 2023 Nov 15, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report Nov 9, 2023 Nov 9, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Nov 1, 2023 Oct 30, 2023
DEF 14C Information statement Sep 25, 2023 Sep 25, 2023
PRE 14C Filing Sep 15, 2023 Sep 11, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
8-K Current report
Listing notice
Jul 20, 2023 Jul 17, 2023
8-K Current report
Listing notice
Jun 26, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 8, 2023 Jun 6, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
DEF 14A Proxy statement Apr 26, 2023 —
10-K Annual report Mar 6, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 6, 2023 Mar 6, 2023
8-K Current report
Other events
Feb 1, 2023 Feb 1, 2023
8-K Current report
Regulation FD disclosure
Jan 6, 2023 Jan 6, 2023
8-K Current report
Listing notice
Dec 23, 2022 Dec 22, 2022
8-K Current report
Officer or director change
Dec 13, 2022 Dec 8, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
8-K Current report
Officer or director change
Aug 15, 2022 Aug 9, 2022
8-K Current report
Officer or director change
Jul 27, 2022 Jul 25, 2022
8-K Current report
Material agreement, Unregistered share sale
Jul 25, 2022 Jul 22, 2022
8-K Current report
Officer or director change
Jul 15, 2022 Jul 11, 2022
8-K Current report
Shareholder vote results
Jun 3, 2022 Jun 1, 2022
8-K Current report
Material agreement, Unregistered share sale
Jun 1, 2022 May 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
DEF 14A Proxy statement May 2, 2022 Jun 1, 2022
8-K Current report
Officer or director change
Apr 15, 2022 Apr 15, 2022
10-K/A Amended annual report Apr 5, 2022 Dec 31, 2021
8-K Current report
Officer or director change
Apr 5, 2022 Mar 30, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 29, 2022 Mar 29, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 3, 2022 Feb 27, 2022
8-K Current report
Listing notice
Feb 18, 2022 Feb 17, 2022
8-K Current report
Other events
Dec 7, 2021 Dec 6, 2021
8-K Current report
Officer or director change
Dec 2, 2021 Dec 1, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Oct 20, 2021 Oct 19, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
CT ORDER Filing Jul 22, 2021 —
8-K Current report
Other events
Jun 25, 2021 Jun 25, 2021
424B5 Prospectus supplement Jun 25, 2021 —
424B3 Prospectus Jun 15, 2021 —
EFFECT Filing Jun 11, 2021 —
CORRESP Letter to the SEC Jun 9, 2021 —
UPLOAD Letter from the SEC Jun 8, 2021 —
S-3 Shelf registration Jun 3, 2021 —
8-K Current report
Results of operations, Bylaw or fiscal year change, Shareholder vote results
May 5, 2021 May 5, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
424B5 Prospectus supplement Apr 21, 2021 —
EFFECT Filing Apr 20, 2021 —
CORRESP Letter to the SEC Apr 16, 2021 —
S-3/A Filing Apr 9, 2021 —
UPLOAD Letter from the SEC Mar 25, 2021 —
S-3 Shelf registration Mar 18, 2021 —
DEFA14A Additional proxy material Mar 18, 2021 —
DEF 14A Proxy statement Mar 18, 2021 May 3, 2021
PRE 14A Preliminary proxy statement Mar 8, 2021 May 3, 2021
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
CT ORDER Filing Feb 18, 2021 —
8-K Current report
Material agreement
Jan 21, 2021 Jan 14, 2021
8-K Current report
Other events
Jan 14, 2021 Jan 14, 2021
424B5 Prospectus supplement Jan 14, 2021 —
8-K Current report
Officer or director change, Other events
Dec 30, 2020 Dec 23, 2020
8-K Current report
Unregistered share sale
Dec 17, 2020 Dec 17, 2020
8-K Current report
Material agreement
Dec 15, 2020 Dec 11, 2020
8-K Current report
Unregistered share sale, Officer or director change
Dec 10, 2020 Dec 10, 2020
424B3 Prospectus Dec 9, 2020 —
EFFECT Filing Dec 8, 2020 —
CORRESP Letter to the SEC Dec 4, 2020 —
UPLOAD Letter from the SEC Dec 2, 2020 —
S-1 Registration statement Nov 24, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Nov 24, 2020 Nov 24, 2020
8-K Current report
Officer or director change
Nov 17, 2020 Nov 16, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations, Other events
Oct 26, 2020 Oct 26, 2020
8-K Current report
Officer or director change
Oct 2, 2020 Sep 30, 2020
8-K Current report
Officer or director change
Sep 1, 2020 Aug 31, 2020
S-8 Employee stock plan registration Aug 3, 2020 —
8-K Current report
Results of operations
Aug 3, 2020 Aug 3, 2020
10-Q Quarterly report Aug 3, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Jun 26, 2020 Jun 23, 2020
8-K Current report
Shareholder vote results
Jun 15, 2020 Jun 11, 2020
DEFA14A Additional proxy material May 22, 2020 —
8-K Current report
Unregistered share sale
May 12, 2020 May 12, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 30, 2020 —
DEF 14A Proxy statement Apr 30, 2020 Jun 11, 2020
424B5 Prospectus supplement Apr 24, 2020 —
8-K Current report
Material agreement
Apr 24, 2020 Apr 24, 2020
8-K Current report
Material agreement
Apr 7, 2020 Apr 1, 2020
8-K Current report
Unregistered share sale
Feb 25, 2020 Feb 25, 2020
8-K Current report
Results of operations
Feb 21, 2020 Feb 20, 2020
10-K Annual report Feb 21, 2020 Dec 31, 2019
8-K Current report
Unregistered share sale
Jan 28, 2020 Jan 28, 2020
D Filing Jan 17, 2020 —
8-K Current report
Unregistered share sale
Jan 7, 2020 Jan 7, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 23, 2019 Dec 23, 2019
8-K Current report
Unregistered share sale
Dec 18, 2019 Dec 18, 2019
8-K Current report
Officer or director change
Nov 29, 2019 Nov 25, 2019
8-K Current report
Unregistered share sale
Nov 26, 2019 Nov 26, 2019
8-K Current report
Unregistered share sale
Nov 12, 2019 Nov 12, 2019
8-K Current report
Results of operations
Oct 31, 2019 Oct 30, 2019
10-Q Quarterly report Oct 30, 2019 Sep 30, 2019
8-K Current report
Unregistered share sale
Oct 25, 2019 Oct 24, 2019
D Filing Oct 15, 2019 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 30, 2019 Sep 26, 2019
8-K Current report
Unregistered share sale
Sep 18, 2019 Sep 18, 2019
8-K Current report
Officer or director change
Sep 17, 2019 Sep 11, 2019
8-K Current report
Unregistered share sale
Sep 11, 2019 Sep 11, 2019
8-K Current report
Unregistered share sale
Sep 4, 2019 Sep 4, 2019
8-K Current report
Unregistered share sale
Aug 6, 2019 Aug 6, 2019
8-K Current report
Results of operations
Jul 31, 2019 Jul 31, 2019
10-Q Quarterly report Jul 31, 2019 Jun 30, 2019
EFFECT Filing Jul 15, 2019 —
CORRESP Letter to the SEC Jul 11, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VTVT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
High Point, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1641489

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.